Stock comparison
REVVITY, INC. is 10.2x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($12.53 B vs $1.23 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RVTY is larger
REVVITY, INC. is 10.2x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($12.53 B vs $1.23 B).
Market value leader
RVTY
REVVITY, INC. is 10.2x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($12.53 B vs $1.23 B).
Revenue leader
RVTY
EYPT: $31.37M vs RVTY: $2.86B.
Profit leader
RVTY
EYPT: -$231.96M vs RVTY: $241.20M.
Margin leader
RVTY
EYPT: -739.4% vs RVTY: 8.4% net margin.
| Metric | EYPT | RVTY |
|---|---|---|
| Market cap | $1.23 B | $12.53 B |
| US-listed rank | #2501 | #819 |
| Revenue (latest FY) | $31.37M | $2.86B |
| Net income (latest FY) | -$231.96M | $241.20M |
| Net margin | -739.4% | 8.4% |
| P/E (trailing FY) | - | 51.9x |
| SEC filings | 1,308 | 1,745 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
REVVITY, INC. is 10.2x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($12.53 B vs $1.23 B).
In their latest fiscal years, EyePoint Pharmaceuticals, Inc. reported $31.37M in revenue while REVVITY, INC. reported $2.86B.
Full pages: EyePoint Pharmaceuticals, Inc. and REVVITY, INC., or browse the full rankings.